StemCyte, Inc.
 | |
| Subsidiary of a publicly traded company | |
| Traded as | Parent: Template:TPEx (StemCyte International, Ltd.) |
| ISIN | 🆔 |
| Industry | BiotechnologyCord blood bankingCell therapy |
| Founded 📆 | 1997 in California |
| Founders 👔 | Robert ChowLawrence D. Petz |
| Headquarters 🏙️ | , , United States |
Area served 🗺️ | |
Key people | Jonas Wang, PhD (Chairman)Tong-Young Lee, PhD (CEO)Joseph Rosenthal, MD (CMO) |
| Products 📟 | REGENECYTE (HPC, Cord Blood) |
| Members | |
Number of employees | |
| Parent | StemCyte International, Ltd. |
| Subsidiaries | StemCyte Taiwan Cord Blood Bank |
| 🌐 Website | stemcyte |
| 📇 Address | |
| 📞 telephone | |
StemCyte, Inc. is an American biotechnology company that operates a cord blood bank and develops cell therapies from umbilical cord blood. Two physicians founded the company in California in 1997: transfusion medicine specialist Lawrence D. Petz and Robert Chow.[1] Headquarters are in Baldwin Park, California. A sister institution, StemCyte Taiwan Cord Blood Bank, operates in Asia.[2]
In November 2024, the Food and Drug Administration approved StemCyte's Biologics license application for REGENECYTE, an allogeneic cord blood-derived therapy used in unrelated-donor hematopoietic stem cell transplantation.[3][4] Prior FDA licenses for HPC, Cord Blood products had all gone to hospital systems, academic medical centers, or nonprofit blood centers. REGENECYTE was the first issued to a commercial biotechnology company.[5]
A cord blood unit identified through StemCyte's registry was used in the 2017 transplant of the "New York patient," an American woman who achieved sustained HIV-1 remission after a haplo-cord transplant at NewYork–Presbyterian / Weill Cornell Medicine.[6] The peer-reviewed report appeared in Cell in March 2023.[7]
StemCyte holds AABB accreditation (since 2002) and Foundation for the Accreditation of Cellular Therapy (FACT) accreditation (since 2006).[8][9] Its parent company, StemCyte International, Ltd., trades on the Taipei Exchange under ticker 4178.[10]
History
Petz and Chow founded StemCyte in California in 1997.[1] StemCyte Taiwan Cord Blood Bank launched in 2000.[2] The U.S. and Taiwan operations received AABB accreditation in 2002,[8] and FACT accreditation in 2006.[9] The FDA approved REGENECYTE on November 20, 2024 under U.S. License No. 2280.[3]
See also
References
- ↑ 1.0 1.1 "Who We Are — Milestones and History". StemCyte, Inc. Retrieved 2026-05-07.
- ↑ 2.0 2.1 "About StemCyte Taiwan Cord Blood Bank". StemCyte Taiwan. Retrieved 2026-05-07.
- ↑ 3.0 3.1 "Approved Cellular and Gene Therapy Products: HPC, Cord Blood (REGENECYTE) — StemCyte, Inc". U.S. Food and Drug Administration. Retrieved 2026-05-07.
- ↑ Cunningham, Jonah (2024-11-26). "FDA Approves StemCyte's Cord Blood Cell Therapy Regenecyte for Unrelated Donor Hematopoietic Progenitor Cell Transplantation Procedures". CGTlive.
- ↑ "StemCyte First Biotech to Receive FDA Approval of a Cord Blood Derived Cellular Therapeutic". BioInformant. 2024-12-04.
- ↑ Mandavilli, Apoorva (2022-02-15). "A Woman Is Cured of H.I.V. Using a Novel Treatment". The New York Times.
- ↑ Hsu, Jingmei; Van Besien, Koen; Glesby, Marshall J.; et al. (2023). "HIV-1 viremic control by a haplo-cord transplant of CCR5 Δ32/Δ32 stem cells in a woman with leukemia". Cell. 186 (6): 1115–1126.e8. doi:10.1016/j.cell.2023.02.030. PMID 36931243 Check
|pmid=value (help). - ↑ 8.0 8.1 "AABB Accredited Cord Blood Facilities". AABB. Retrieved 2026-05-07.
- ↑ 9.0 9.1 "Accredited Cord Blood Banks". Foundation for the Accreditation of Cellular Therapy. Retrieved 2026-05-07.
- ↑ "StemCyte International Ltd. (4178) — Listed Companies". Taipei Exchange. Retrieved 2026-05-07.
Category:Cord blood banks Category:Biotechnology companies of the United States Category:Companies based in Baldwin Park, California Category:Cell therapy Category:Biotechnology companies established in 1997 Category:1997 establishments in California
 | This corporation or company article is a stub. You can help EverybodyWiki by expanding it. |
This article "StemCyte" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:StemCyte. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
